LUMICKS invites you to attend our immuno-oncology webinars.

The series of webinars, delivered by our application scientists or by invited speakers, cover topics across the field of immunotherapy, such as CAR-T and TCR T-cell therapy.

If you are curious about cell avidity or are looking for a new workflow that can help you predict the immunotherapeutic potential of your cells, click on the link below to register to our webinars or download recordings!

Keynote speaker webinars

Watch webinars from world-leading experts.

Don’t miss world-renowned researchers talk about their experience with cell avidity measurements for T cell functionality prediction.

Dr. John Maher Leucid Bio

CAR T-Cell Immunotherapy of Solid Tumors – Learning from the Clinic and Lab in Parallel

Learn about Leucid Bio’s efforts in developing a next generation CAR platform, known as parallel (p)CAR. How does Dr. John Maher use the z-Movi to address the importance of relative binding affinity in the design of optimized pCAR?

Watch it on-demand

Dual-targeted cell therapy targeting BCMA and GPRCD5 to prevent relapse in multiple myeloma

Learn from Prof. de Larrea how expressing two CARs on a single cell enhances the strength of CAR T-cell/target cell interactions, prevents BCMA escape-driven relapse, and how cell avidity measurements contributed to their findings.

Watch it on-demand

Exploring the network of cellular interactions of NK cells in the tumor microenvironment 

Learn from Dr. Mark Lowdell how the NK cells primed by INKmune, a proprietary NK-priming technology developed by INmune, become effective against resistant tumor cell, and how the cell avidity measurements with the z-Movi was used to validate it by depicting a stronger binding between NK and tumor cells.

Register here

Application webinars

Deep-dive into the applications with LUMICKS’ scientists.

Join our upcoming webinars presented by expert speakers, covering the latest breakthroughs and developments in immuno-oncology.

Cellular avidity: a missing link for efficacious immunotherapy

Explore experiments across the topics of CAR-T cells, TCR T cells, NK cells, and bispecific antibody-engaged T cells, showing a correlation between avidity and T cell functionality.

Rapid identification of Goldilocks CAR T cells using z-Movi® Cell Avidity Analyzer

Discover how measuring cellular avidity using the z-Movi Cell Avidity Analyzer helps researchers to quickly identify optimal functioning CARs and compare between panels.

Fast and accurate prediction of optimal TCR function using z-Movi® Cell Avidity Analyzer

How does the z-Movi Cell Avidity Analyzer measure cell avidity? Why does avidity matter in TCR-dependent T-cell cytotoxicity? How does it compare with functional assays?

Unveiling a one-to-one relationship of TCR-dependent T cell function and cellular avidity

We present avidity data, obtained by Dr. Nathalie Rufer’s research team at the University of Lausanne, showing a linear correlation between T cell function and cell avidity.

Watch past webinars

Missed a webinar? Watch it on-demand below. A video recording and a slide deck are now available on our website.

Fill in the form below to watch previously-held webinars. If you miss something don’t hesitate to let us know!

Join our mailing list.

Get exclusive news on the latest products, single-molecule events and breakthrough science.

By agreeing to receive marketing communications, you subscribe to our newsletter. You can change your mind at any time by clicking the unsubscribe link in any marketing email you receive from us. By submitting the form you agree to LUMICKS' privacy policy.